Corcept Therapeutics (FRA:HTD) Current Accrued Expense : €54.3 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Corcept Therapeutics Current Accrued Expense?

Corcept Therapeutics's Current Accrued Expense for the quarter that ended in Mar. 2024 was €54.3 Mil.

Corcept Therapeutics's quarterly Current Accrued Expense increased from Sep. 2023 (€51.0 Mil) to Dec. 2023 (€53.1 Mil) and increased from Dec. 2023 (€53.1 Mil) to Mar. 2024 (€54.3 Mil).

Corcept Therapeutics's annual Current Accrued Expense increased from Dec. 2021 (€23.0 Mil) to Dec. 2022 (€40.6 Mil) and increased from Dec. 2022 (€40.6 Mil) to Dec. 2023 (€53.1 Mil).

Corcept Therapeutics Current Accrued Expense Historical Data

The historical data trend for Corcept Therapeutics's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corcept Therapeutics Current Accrued Expense Chart

Corcept Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

15.67

20.34

22.97

40.60

53.15

Corcept Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															46.20	46.86	50.96	53.15	54.28

Corcept Therapeutics Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Corcept Therapeutics Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Corcept Therapeutics's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Corcept Therapeutics (FRA:HTD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corcept Therapeutics Inc (FRA:HTD) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

CORT:USA

Address

149 Commonwealth Drive, Menlo Park, CA, USA, 94025

Website

https://www.corcept.com

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.